Ad is loading...
MDGL
Price
$329.24
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
96 days until earnings call
MREO
Price
$3.68
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
124 days until earnings call
Ad is loading...

MDGL vs MREO

Header iconMDGL vs MREO Comparison
Open Charts MDGL vs MREOBanner chart's image
Madrigal Pharmaceuticals
Price$329.24
Change-$0.00 (-0.00%)
Volume$423.64K
CapitalizationN/A
Mereo BioPharma Group
Price$3.68
Change-$0.00 (-0.00%)
Volume$864.94K
CapitalizationN/A
MDGL vs MREO Comparison Chart
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MDGL vs. MREO commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a StrongBuy and MREO is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (MDGL: $347.45 vs. MREO: $3.72)
Brand notoriety: MDGL and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 119% vs. MREO: 78%
Market capitalization -- MDGL: $7.58B vs. MREO: $577.14M
MDGL [@Biotechnology] is valued at $7.58B. MREO’s [@Biotechnology] market capitalization is $577.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 1 green, 4 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than MREO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 5 TA indicator(s) are bullish while MREO’s TA Score has 4 bullish TA indicator(s).

  • MDGL’s TA Score: 5 bullish, 6 bearish.
  • MREO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than MREO.

Price Growth

MDGL (@Biotechnology) experienced а +20.40% price change this week, while MREO (@Biotechnology) price change was +5.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

MDGL is expected to report earnings on Feb 26, 2025.

MREO is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($7.58B) has a higher market cap than MREO($577M). MREO YTD gains are higher at: 59.307 vs. MDGL (42.294). MREO has higher annual earnings (EBITDA): -43.41M vs. MDGL (-502.65M). MDGL has more cash in the bank: 999M vs. MREO (80.5M). MREO has less debt than MDGL: MREO (6.68M) vs MDGL (119M). MDGL has higher revenues than MREO: MDGL (76.8M) vs MREO (1M).
MDGLMREOMDGL / MREO
Capitalization7.58B577M1,313%
EBITDA-502.65M-43.41M1,158%
Gain YTD42.29459.30771%
P/E RatioN/AN/A-
Revenue76.8M1M7,680%
Total Cash999M80.5M1,241%
Total Debt119M6.68M1,781%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLMREO
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRMDX15.190.19
+1.27%
Heartland Mid Cap Value Investor
LSOFX19.010.16
+0.85%
LS Opportunity Fund Institutional Class
MFRFX64.450.41
+0.64%
MFS Research A
FPPVX11.93N/A
N/A
MFS Prudent Investor R6
DWGHX10.81-0.04
-0.37%
American Funds Dvlpg Wld Gr&Inc F2

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+3.83%
KANT - MDGL
62%
Loosely correlated
N/A
VXRT - MDGL
61%
Loosely correlated
-1.40%
ALXO - MDGL
56%
Loosely correlated
+6.61%
REPL - MDGL
55%
Loosely correlated
-1.60%
ZNTL - MDGL
51%
Loosely correlated
+1.60%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+2.79%
MDGL - MREO
37%
Loosely correlated
+3.83%
INZY - MREO
34%
Loosely correlated
-3.58%
TERN - MREO
34%
Loosely correlated
+1.96%
XERS - MREO
33%
Loosely correlated
-0.65%
ARRY - MREO
30%
Poorly correlated
-0.63%
More